COMMUNIQUÉS West-GlobeNewswire

-
MedTech Manufacturer Juvent Joins the Inc. 5000 List of America’s Fastest-Growing Private Companies
12/08/2025 -
Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update
12/08/2025 -
Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates
12/08/2025 -
Biotricity to Host Fiscal 2026 First Quarter Financial Results and Business Update Call on August 14th
12/08/2025 -
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
12/08/2025 -
NetraMark Appoints Jan Sedway as Senior Vice President of Clinical Science to Accelerate Growth and Market Leadership
12/08/2025 -
Quoin Pharmaceuticals Releases Fourth Episode in NETHERTON NOW Video Series Featuring International Patient Advocate Mandy Aldwin-Easton
12/08/2025 -
Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025
12/08/2025 -
AVITA Medical Successfully Completes Australian Equity Raise
12/08/2025 -
Fifty1 Labs, Inc. and BioSpark AI Unlock 2,000+ Real-World Treatment Pathways to Accelerate Functional Medicine Innovation
12/08/2025 -
Branded Legacy, Inc. Finalizes Transformative Acquisition of Bio Legacy Evaluative Group (f/k/a Menlo Health), Unlocking Explosive Growth Potential in Biotech and Drug Delivery
12/08/2025 -
Safety Shot Acquires 10% Revenue Sharing Interest in Revenue Generating BONK.fun and Appoints BONK Founding Core Members to Board
12/08/2025 -
Trinity Biotech Achieves Breakthrough Clinical Trial Results for Redesigned CGM Sensor
12/08/2025 -
ALK upgrades its full-year revenue outlook
12/08/2025 -
LiveWorld Reports Second Quarter 2025 Financial Results
12/08/2025 -
HealthEquity Community Foundation Expands National Impact with $50,000 in Grants
12/08/2025 -
TOMI Environmental Solutions Announces Major New Customer Win for 2025
12/08/2025 -
All Heart Homecare Agency Celebrates 13 Years of Compassionate Care
12/08/2025 -
Senti Bio Participates in Virtual Investor “What This Means” Segment Discussing The Phase 2 Dose and Schedule Selection for SENTI-202 in its Clinical Trial for Acute Myeloid Leukemia
12/08/2025
Pages